期刊文献+

透析前慢性肾衰患者促红细胞生成素的应用 被引量:1

下载PDF
导出
摘要 目的探讨早期使用促红细胞生成素(EPO)治疗肾性贫血的临床疗效。方法慢性肾衰非透析患者80例,采用随机分组对照的原则,治疗组给予EPO2000U每周2次,皮下注射,观察12周;对照组给予每周两次不含EPO的溶液。结果两组治疗前各项指标无显著差异(P>0.05),治疗组应用EPO治疗12周后与治疗前及对照组比较,血压、血BUN及血Cr无显著差异(P>0.05),而HCT、Hb及血清铁有显著性差异(P<0.05)。结论小剂量应用EPO对慢性肾功能不全非透析患者的肾性贫血是有效而且安全的治疗方法。
作者 许武红
出处 《中原医刊》 2005年第14期7-8,共2页 Central Plains Medical Journal
  • 相关文献

参考文献4

  • 1Garicia Anderson S, Rennke HG, Brenner BM. Anemia lessens and its Prevention with reconbinant human erythro - poietin worsens glomerular injury and hypertenscin in rats with reduced renal mass. Proc Natl AcadSci USA,1988,85:6142 ~6146.
  • 2Mege JL,Olmer M, Purgus R,et al . Hemodialysis Membranes modulate Chronically the Procluction otTNF alpha, IL beta anel LLb Nephrol Dial Transplant, 1991,6:868 ~ 875.
  • 3FoleyKN, ParfneyPs, sarnakMJ. Thedinicalepdemiol-ogyofCardiovaseular diseast in chronic renal disease. Am J Kidney Dis, 1998,32[ Supp13 ] :112 ~ 119.
  • 4Valderrabano F, gualify ot life benefits of early anemia treatment. Nephrol Dial Transplant,2000,15 [ Supp13 ] :23 ~ 28.

同被引文献15

  • 1周成慧,彭佑铭.Darbepoetinα治疗慢性肾衰竭引发的贫血[J].世界临床药物,2005,26(2):91-95. 被引量:3
  • 2冯德月,潘志铣,伍锦泉.重组促红细胞生成素治疗慢性肾衰贫血的疗效-费用分析[J].中国基层医药,2005,12(8):977-978. 被引量:3
  • 3张红伟.重组人红细胞生成素治疗慢性肾衰贫血20例疗效观察[J].中国误诊学杂志,2005,5(18):3487-3488. 被引量:3
  • 4Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] [DB/OL]. The Cochrane Collaboration,2008. Available from www.coehrane-handbook.org.
  • 5Cianciaruso B, Ravani P, Barrett BJ, et al.Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease [J]. J Nephrol, 2008,21 (6) : 861-870.
  • 6Macdougall IC, Temple RM, Kwan JT. Is early treatment of anaemia with Epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients .9 Results of a muhicentre, open- label, prospective, randomized, comparative group trial [J]. Nephrol Dial Transplant, 2007,22 (3) : 784-793.
  • 7Roger SD, McMahon LP, Clarkson A, et al. Effects of early and late intervention with Epoetin of on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial [J]. J Am Soc Nephrol, 2004, 15 (1) : 148-156.
  • 8Kuriyama S, Tomonari H, Yoshida H, et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetie patients [J].Nephron, 1997,77(2) : 176-185.
  • 9Lim VS, DeGowin RL, Zavala D, et al. Recombinant human erthropoietin treatment in pre-dialysis patients.A double-blind placebo-controlled trial [J]. Ann Intern Med, 1989,110(2): 108-114.
  • 10The US Recombinant Human Erythropoietin Predialysis Study Group. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients [J]. Am J Kidney Dis, 1991,18 ( 1 ) : 50-59.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部